Therefore, targeting the cGAS‐STING signaling pathway highlights the potential for broad‐therapeutic treatment of antiviral‐induced neuroinflammation in PD and other neurodegenerative diseases. This evidence concerns the gene CGAS and neurodegenerative disease.